The AMA applauded the Texas Medical Association for defeating dozens of scope of practice creep bills in the Texas legislature this year.

CVRx has now received improved outpatient and inpatient reimbursements for its implantable heart failure device in the last 12 months. The company's president says these updates will help more patients gain access to the Barostim technology. 

Bharath Krishnamurthy, a director of health policy and analytics at the American Hospital Association, explains the financial impact of current healthcare staffing shortages.

The drugmaker argues that the FDA's recent approval of a generic version of Entresto should not be allowed for multiple reasons. Novartis sent multiple requests to the agency hoping to stop the approval, but the FDA denied each one. 

Despite raging inflation and rising staff costs, the conversion factor is the lowest it’s been since 1993, Richard Heller, MD, MBA, wrote for MedPage Today. 

Three years after a pair of former hospital C-suite executives blew the whistle on their own institution, the U.S. Department of Justice has acted on the complaint.

The new medical device correction only includes a select number of devices. Abbott said they produce inaccurate readings, putting patient health at risk. 

The newly cleared device includes a rapid-exchange catheter and a helical balloon that takes the shape of a hollow cylinder when inflated.